Globela Pharma Private Limited — Erythromycin Exporter Profile
Indian Pharmaceutical Exporter · #14 for Erythromycin · $750.0K export value · DGFT Verified
Globela Pharma Private Limited is the #14 Indian exporter of Erythromycin with $750.0K in export value and 15 verified shipments. Globela Pharma Private Limited holds a 0.9% market share in Erythromycin exports across 2 countries. The company exports 9 pharmaceutical products worth $3.3M across 5 therapeutic categories.
Globela Pharma Private Limited — Erythromycin Export Profile: Buyers & Destinations
Where Does Globela Pharma Private Limited Export Erythromycin?
Globela Pharma Private Limited exports Erythromycin to 2 countries. The largest destination is NIGERIA accounting for 96.7% of Globela Pharma Private Limited's Erythromycin shipments. These destinations reflect Globela Pharma Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Erythromycin from Globela Pharma Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| EVERDESTINY PHARMACEUTICALS LIMITED | NIGERIA | $255.5K | 6 |
| UCHE ST PHARMACEUTICAL COMPANY LIMI | NIGERIA | $141.1K | 3 |
| E P LTD | NIGERIA | $100.0K | 2 |
| TO THE ORDER OF | NIGERIA | $69.1K | 2 |
| EXCELMED PHARMACEUTICALS INC | LIBERIA | $19.1K | 2 |
Globela Pharma Private Limited supplies Erythromycin to 5 buyers globally. The largest buyer is EVERDESTINY PHARMACEUTICALS LIMITED (NIGERIA), followed by UCHE ST PHARMACEUTICAL COMPANY LIMI (NIGERIA) and E P LTD (NIGERIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Erythromycin Export Value and How Much Does Globela Pharma Private Limited Contribute?
India exported $19.0M worth of Erythromycin through 3,939 shipments from 368 suppliers to 135 countries, serving 992 buyers globally. Globela Pharma Private Limited contributes $750.0K to this total, accounting for 0.9% of India's Erythromycin exports. Globela Pharma Private Limited ships Erythromycin to 2 countries through 5 buyers.
What Is the Average Shipment Value for Globela Pharma Private Limited's Erythromycin Exports?
Globela Pharma Private Limited's average Erythromycin shipment value is $50.0K per consignment, based on 15 shipments totaling $750.0K. The largest destination is NIGERIA (96.7% of Globela Pharma Private Limited's Erythromycin exports).
How Does Globela Pharma Private Limited Compare to Other Indian Erythromycin Exporters?
Globela Pharma Private Limited ranks #14 among 368 Indian Erythromycin exporters with a 0.9% market share. The top 3 exporters are MEDOPHARM ($3.0M), S KANT HEALTHCARE LIMITED ($2.8M), MEDREICH LIMITED ($2.1M). Globela Pharma Private Limited processed 15 shipments to 2 destination countries.
What Erythromycin Formulations Does Globela Pharma Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ERYGLOB (PACK 10X10'S) (ERYTHROMYCINE STEARATE TABLETS BP 500 MG) (BATCH NO GT23578 TO 582 MFG DT 11/2023 EXP DT 10/2026NOS | $141.1K | 3 |
| ERYTHROMAX (PACK 1 NOS)(ERYTHROMYCINE ST | $100.0K | 2 |
| ERYGLOB PACK 10x1x10 s ERYTHROMYCINESTEARATE TABLETS BP 500 MG | $50.0K | 1 |
| ERYTHROMAX (PACK 10X1X10 S) (ERYTHROMYCINE STEARATE TABLETS BP 500 MG) | $50.0K | 1 |
| ERYTHROMAX PACK 10x1x10's ERYTHROMYCINE STEARATE TABLETS BP 500 MG BATCH NOGT23311 TO 16 MANUFACTURING DT 06/2023 EXP DT 05/ | $50.0K | 1 |
| ERYTHROMAX PACK 1's ERYTHROMYCINE STEARATE TABLETS BP 500 MG BATCH NO GT23311 TO 16 MANUFACTURING DT 06/2023 EXP DT 05/2026 | $50.0K | 1 |
| ERYTHROMAX ( PACK 10X1X10'S) (ERYTHROMYCINE STEARATE TABLETS BP 500 MG)BATCH NOGT23410 TO 14 MFG DT 08/2023 EXP DT 07/2 | $50.0K | 1 |
| EVERDESTINY AZITHROMYCIN SUSPENSION PACK 10X1X10S ERYTHROMYCINE STEARATE TABLETS BP 500 MG QTY IN PACK 10000 OTHER | $48.4K | 1 |
| ERYGLOB PACK 1 s ERYTHROMYCINE STEARATE TABLETS BP 500 MG | $19.1K | 1 |
| GLOMYCIN PACK 10x1x10's ERYTHROMYCIN STEARATE TABLETS BP 500 MG BATCH NO GT23529 MANUFACTURING DT 07/2023 EXP DT 06/2026 | $19.1K | 2 |
Globela Pharma Private Limited exports 11 distinct Erythromycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ERYGLOB (PACK 10X10'S) (ERYTHROMYCINE STEARATE TABLETS BP 50 with 3 shipments worth $141.1K.
Regulatory Requirements: Exporting Erythromycin to Key Markets
What Globela Pharma Private Limited must comply with to export Erythromycin to its top destination countries
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Globela Pharma Private Limited Compare to Nearest Erythromycin Exporters?
Exporters ranked immediately above and below #14 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | BDH INDUSTRIES LIMITED | $850.0K | 17 | 7 | $50.0K |
| 12 | SIDHAANT LIFE SCIENCES PRIVATE LIMITED | $750.0K | 15 | 6 | $50.0K |
| 14 | GLOBELA PHARMA PRIVATE LIMITED ★ | $750.0K | 15 | 2 | $50.0K |
| 3 | LINCOLN PHARMACEUTICALS LTD | $550.0K | 11 | 4 | $50.0K |
| 8 | MEDOPHARM PRIVATE LIMITED | $500.0K | 10 | 2 | $50.0K |
Globela Pharma Private Limited ranks #14 among 368 Indian Erythromycin exporters. Average shipment value of $50.0K compared to the market average of $51.7K. The closest competitors by value are BDH INDUSTRIES LIMITED and SIDHAANT LIFE SCIENCES PRIVATE LIMITED.
Which Indian Ports Ship Erythromycin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 513 | 13.0% |
| DELHI AIR CARGO ACC (INDEL4) | 394 | 10.0% |
| SAHAR AIR | 377 | 9.6% |
| NHAVA SHEVA SEA (INNSA1) | 370 | 9.4% |
| JNPT/ NHAVA SHEVA SEA | 234 | 5.9% |
| DELHI AIR | 227 | 5.8% |
| JNPT | 176 | 4.5% |
| Bombay Air | 99 | 2.5% |
About Globela Pharma Private Limited
Globela Pharma Private Limited exports 9 products worth $3.3M. Beyond Erythromycin, top products include Fluconazole, Febuxostat, Ritonavir, Letrozole, Anastrozole. View the complete Globela Pharma Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Erythromycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Erythromycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Globela Pharma Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 15 individual customs records matching Globela Pharma Private Limited exporting Erythromycin, covering 11 formulations to 2 countries via 5 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 135+ countries, 992+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Erythromycin Export Data from Globela Pharma Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Globela Pharma Private Limited's Erythromycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Globela Pharma Private Limited
Full Company Profile →
9 products · $3.3M total trade · 5 categories
Erythromycin Stats
Company Overview
Top Products by Globela Pharma Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Globela Pharma Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Erythromycin. For current shipment-level data, contact TransData Nexus.